TABLE 3

Hepatic pharmacokinetics of Gd-DTPA and Gd-BOPTA by compartmental analysis

Values are presented as means ± S.D.

Perfused [BOPTA]p
40 μM100 μM200 μM400 μM800 μM1600 μM
k12
    SD1.4 ± 0.21.7 ± 0.21.4 ± 0.31.4 ± 0.21.3 ± 0.41.3 ± 0.20.42
    TR1.4 ± 0.21.9 ± 0.41.2 ± 0.31.7 ± 0.41.6 ± 0.21.3 ± 0.30.36
k24 BOPTA
    SD1.6 ± 0.21.7 ± 0.21.5 ± 0.21.0 ± 0.41.0 ± 0.40.5 ± 0.110.02
    TR0.8 ± 0.10.7 ± 0.10.6 ± 0.10.5 ± 0.10.3 ± 0.10.2 ± 0.10.01
k24 DTPA
    SD0.01 ± 0.010.01 ± 0.010.01 ± 0.010.01 ± 0.010.01 ± 0.010.01 ± 0.010.76
    TR000000
k42
    SD0.06 ± 0.010.08 ± 0.010.12 ± 0.040.10 ± 0.060.44 ± 0.170.12 ± 0.090.05
    TR<0.005<0.005<0.005<0.005<0.005<0.0050.23
k46
    SD0.09 ± 0.010.09 ± 0.010.11 ± 0.030.12 ± 0.010.15 ± 0.010.12 ± 0.030.06
    TR000000
k45
    SD0.02 ± 0.010.04 ± 0.010.08 ± 0.030.10 ± 0.020.26 ± 0.050.18 ± 0.060.006
    TR000000
k56
    SD0.03 ± 0.010.04 ± 0.010.05 ± 0.010.05 ± 0.010.05 ± 0.010.04 ± 0.010.10
    TR000000
k23
    SD9.6 ± 1.510.7 ± 2.410.9 ± 1.310.3 ± 0.69.1 ± 2.310.1 ± 1.50.65
    TR12.1 ± 1.811.7 ± 2.510.3 ± 2.711.9 ± 1.510.2 ± 1.59.7 ± 1.60.54
  • SD, Sprague-Dawley rats.